<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">30862068</PMID><DateCompleted><Year>2019</Year><Month>06</Month><Day>21</Day></DateCompleted><DateRevised><Year>2020</Year><Month>02</Month><Day>25</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1420-3049</ISSN><JournalIssue CitedMedium="Internet"><Volume>24</Volume><Issue>5</Issue><PubDate><Year>2019</Year><Month>Mar</Month><Day>11</Day></PubDate></JournalIssue><Title>Molecules (Basel, Switzerland)</Title><ISOAbbreviation>Molecules</ISOAbbreviation></Journal><ArticleTitle>Synthesis and Broad Antiviral Activity of Novel 2-aryl-isoindolin-1-ones towards Diverse Enterovirus A71 Clinical Isolates.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">985</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/molecules24050985</ELocationID><Abstract><AbstractText>Enterovirus 71 (EV-A71) is the main causative pathogen of childhood hand, foot and mouth disease. Effective medicine is currently unavailable for the treatment of this viral disease. Using the fragment-hopping strategy, a series of 2-aryl-isoindolin-1-one compounds were designed, synthesized and investigated for their in vitro antiviral activity towards multiple EV-A71 clinical isolates (H, BrCr, Shenzhen98, Jiangsu52) in Vero cell culture in this study. The structure&#x207b;activity relationship (SAR) studies identified 2-phenyl-isoindolin-1-ones as a new potent chemotype with potent antiviral activity against EV-A71. Ten out of the 24 tested compounds showed significant antiviral activity (EC<sub>50</sub> &lt; 10 &#xb5;M) towards four EV-A71 strains. Compounds <b>A3</b> and <b>A4</b> exhibited broad and potent antiviral activity with the 50% effective concentration (EC<sub>50</sub>) values in the range of 1.23&#x207b;1.76 &#x3bc;M. Moreover, the selectivity indices of <b>A3</b> and <b>A4</b> were significantly higher than those of the reference compound, pirodavir. The western blotting experiment indicated that the viral VP1 was significantly decreased at both the protein and RNA level in a dose-dependent manner following treatment with compound <b>A3</b>. Moreover, compound <b>A3</b> inhibited the viral replication by acting on the virus entry stage. In summary, this study led to the discovery of 2-aryl-isoindolin-1-ones as a promising scaffold with potent anti-EV-A71 activities, which deserves further in-depth studies.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Yixuan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>CAMS Key Laboratory of Antiviral Drug Research, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, 1 Tiantanxili, Beijing 100050, China. 18645148632@163.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Huiqiang</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>CAMS Key Laboratory of Antiviral Drug Research, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, 1 Tiantanxili, Beijing 100050, China. wanghuiqiang@imb.pumc.edu.cn.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Beijing Key Laboratory of Antimicrobial Agents, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, 1 Tiantanxili, Beijing 100050, China. wanghuiqiang@imb.pumc.edu.cn.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jiang</LastName><ForeName>Xinbei</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>CAMS Key Laboratory of Antiviral Drug Research, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, 1 Tiantanxili, Beijing 100050, China. Jiangxinbei2011@163.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jiang</LastName><ForeName>Zhi</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>CAMS Key Laboratory of Antiviral Drug Research, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, 1 Tiantanxili, Beijing 100050, China. jiangzhi450@163.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guo</LastName><ForeName>Tingting</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>CAMS Key Laboratory of Antiviral Drug Research, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, 1 Tiantanxili, Beijing 100050, China. guott2019@163.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Beijing Key Laboratory of Antimicrobial Agents, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, 1 Tiantanxili, Beijing 100050, China. guott2019@163.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ji</LastName><ForeName>Xingyue</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>CAMS Key Laboratory of Antiviral Drug Research, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, 1 Tiantanxili, Beijing 100050, China. jixingyue@imb.pumc.edu.cn.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Yanping</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>CAMS Key Laboratory of Antiviral Drug Research, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, 1 Tiantanxili, Beijing 100050, China. liyanping@imb.pumc.edu.cn.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Yuhuan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>CAMS Key Laboratory of Antiviral Drug Research, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, 1 Tiantanxili, Beijing 100050, China. liyuhuan@imb.pumc.edu.cn.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Beijing Key Laboratory of Antimicrobial Agents, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, 1 Tiantanxili, Beijing 100050, China. liyuhuan@imb.pumc.edu.cn.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Zhuorong</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>CAMS Key Laboratory of Antiviral Drug Research, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, 1 Tiantanxili, Beijing 100050, China. lizhuorong@imb.pumc.edu.cn.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>CAMS Innovation Fund for Medical Sciences (2017-I2M-3-012)</GrantID><Agency>Chinese Academy of Medical Sciences</Agency><Country/></Grant><Grant><GrantID>7132166</GrantID><Agency>Natural Science Foundation of Beijing Municipality</Agency><Country/></Grant><Grant><GrantID>2018ZX09711003</GrantID><Agency>National Science and Technology Major Projects for "Major New Drugs Innovation and Development"</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>03</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Molecules</MedlineTA><NlmUniqueID>100964009</NlmUniqueID><ISSNLinking>1420-3049</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D054833">Isoindoles</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName><QualifierName UI="Q000138" MajorTopicYN="Y">chemical synthesis</QualifierName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002460" MajorTopicYN="N">Cell Line</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002522" MajorTopicYN="N">Chlorocebus aethiops</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D029821" MajorTopicYN="N">Enterovirus A, Human</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName><QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015967" MajorTopicYN="N">Gene Expression Regulation, Viral</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D054833" MajorTopicYN="N">Isoindoles</DescriptorName><QualifierName UI="Q000138" MajorTopicYN="Y">chemical synthesis</QualifierName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008826" MajorTopicYN="N">Microbial Sensitivity Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013329" MajorTopicYN="N">Structure-Activity Relationship</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014709" MajorTopicYN="N">Vero Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014779" MajorTopicYN="N">Virus Replication</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">2-aryl-isoindolin-1-ones</Keyword><Keyword MajorTopicYN="N">antiviral</Keyword><Keyword MajorTopicYN="N">enterovirus A71</Keyword><Keyword MajorTopicYN="N">structure activity relationship</Keyword><Keyword MajorTopicYN="N">synthesis</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>2</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>3</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>3</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>3</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>3</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>6</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2019</Year><Month>3</Month><Day>11</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30862068</ArticleId><ArticleId IdType="pmc">PMC6429200</ArticleId><ArticleId IdType="doi">10.3390/molecules24050985</ArticleId><ArticleId IdType="pii">molecules24050985</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ang M.J., Lau Q.Y., Ng F.M., Then S.W., Poulsen A., Cheong Y.K., Ngoh Z.X., Tan Y.W., Peng J., Keller T.H., et al. Peptidomimetic ethyl propenoate covalent inhibitors of the enterovirus 71 3C protease: A P2-P4 study. J. Enzyme Inhib. Med. Chem. 2016;31:332&#x2013;339. doi: 10.3109/14756366.2015.1018245.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/14756366.2015.1018245</ArticleId><ArticleId IdType="pubmed">25792507</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H., Li Y. Recent Progress on Functional Genomics Research of Enterovirus 71. Virol Sin. 2018 doi: 10.1007/s12250-018-0071-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12250-018-0071-9</ArticleId><ArticleId IdType="pmc">PMC6420560</ArticleId><ArticleId IdType="pubmed">30552635</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmidt N., Lennette E., Ho H. An apparently new enterovirus isolated from patients with disease of the central nervous system. J. Infect. Dis. 1974;129:304&#x2013;309. doi: 10.1093/infdis/129.3.304.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/129.3.304</ArticleId><ArticleId IdType="pubmed">4361245</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang S.M., Liu C.C. Update of enterovirus 71 infection: Epidemiology, pathogenesis and vaccine. Expert Rev. Anti Infect. Ther. 2014;12:447&#x2013;456. doi: 10.1586/14787210.2014.895666.</Citation><ArticleIdList><ArticleId IdType="doi">10.1586/14787210.2014.895666</ArticleId><ArticleId IdType="pubmed">24579906</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H., Hu J., Yan H., Wu S., Li Y. Corydaline inhibits enterovirus 71 replication by regulating COX-2 expression. J. Asian Nat. Prod. Res. 2017;19:1124&#x2013;1133. doi: 10.1080/10286020.2017.1386658.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/10286020.2017.1386658</ArticleId><ArticleId IdType="pubmed">29034730</ArticleId></ArticleIdList></Reference><Reference><Citation>Ooi M.H., Wong S.C., Lewthwaite P., Cardosa M.J., Solomon T. Clinical features, diagnosis and management of enterovirus 71. Lancet Neurol. 2010;9:1097&#x2013;1105. doi: 10.1016/S1474-4422(10)70209-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(10)70209-X</ArticleId><ArticleId IdType="pubmed">20965438</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang F., Ren L., Xiong Z., Li J., Xiao Y., Zhao R., He Y., Bu G., Zhou S., Wang J., et al. Enterovirus 71 outbreak in the People&#x2019;s Republic of China in 2008. J. Clin. Microbiol. 2009;47:2351&#x2013;2352. doi: 10.1128/JCM.00563-09.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.00563-09</ArticleId><ArticleId IdType="pmc">PMC2708525</ArticleId><ArticleId IdType="pubmed">19439545</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization  Regional Office for the Western Pacific (2018) Hand, Foot and Mouth Disease Situation Update 2018.  [(accessed on 28 August 2018)]; Available online:  http://iris.wpro.who.int/handle/10665.1/14191.</Citation></Reference><Reference><Citation>Tan C.Y., Gonfrier G., Ninove L., Zandotti C., Dubot-P&#xe9;r&#xe8;s A., de Lamballerie X., Charrel R.N. Screening and detection of human enterovirus 71 infection by a real-time RT-PCR assay in Marseille, France, 2009&#x2013;2011. Clin. Microbiol. Infect. 2012;18:E77&#x2013;E80. doi: 10.1111/j.1469-0691.2012.03769.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1469-0691.2012.03769.x</ArticleId><ArticleId IdType="pubmed">22332991</ArticleId></ArticleIdList></Reference><Reference><Citation>CFDA approved the inactivated EV71 vaccine.  [(accessed on 3 December 2015)]; Available online:  http://samr.cfda.gov.cn/WS01/CL0051/136853.html.</Citation></Reference><Reference><Citation>Ji X., Wang H., Hao L., He W., Gao R., Li Y., Li Y., Jiang J., Li Z. Synthesis and antiviral activity of N-Phenylbenzamide derivatives, a novel class of enterovirus 71 inhibitors. Molecules. 2013;18:3630&#x2013;3640. doi: 10.3390/molecules18033630.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules18033630</ArticleId><ArticleId IdType="pmc">PMC6270001</ArticleId><ArticleId IdType="pubmed">23519203</ArticleId></ArticleIdList></Reference><Reference><Citation>Miyachi H., Azuma A., Hioki E., Kobayashi Y., Iwasaki S., Hashimoto Y. Inducer specific regulators of tumor necrosis factor alpha production. Chem. Pharm. Bull. 1996;44:1980&#x2013;1982. doi: 10.1248/cpb.44.1980.</Citation><ArticleIdList><ArticleId IdType="doi">10.1248/cpb.44.1980</ArticleId><ArticleId IdType="pubmed">8904830</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee H.J., Lim S.J., Oh S.J., Moon D.H., Kim D.J., Tae J., Yoo K.H. Isoindol-1,3-dione and isoindol-1-one derivatives with high binding affinity to &#x3b2;-amyloid fibrils. Bioorg. Med. Chem. Lett. 2008;18:1628&#x2013;1631. doi: 10.1016/j.bmcl.2008.01.066.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bmcl.2008.01.066</ArticleId><ArticleId IdType="pubmed">18242990</ArticleId></ArticleIdList></Reference><Reference><Citation>Breytenbach J.C., Dyk S., Heever I., Allin S.M., Hodkinson C.C., Northfield C.J., Page M.I. Synthesis and antimicrobial activity of some isoindolin-1-ones derivatives. Bioorg. Med. Chem. Lett. 2000;10:1629&#x2013;1631. doi: 10.1016/S0960-894X(00)00306-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0960-894X(00)00306-1</ArticleId><ArticleId IdType="pubmed">10937711</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H., Li K., Ma L., Wu S., Hu J., Yan H., Jiang J., Li Y. Berberine inhibits enterovirus 71 replication by downregulating the MEK/ERK signaling pathway and autophagy. Virol. J. 2017;14:2. doi: 10.1186/s12985-016-0674-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12985-016-0674-4</ArticleId><ArticleId IdType="pmc">PMC5234143</ArticleId><ArticleId IdType="pubmed">28081706</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>